"Cyclobenzaprine" Pill Images
The following drug pill images match your search criteria.

TV W52
1 / 2
Loading
WATSON 3330
MP 578
Cyclobenzaprine Hydrochloride
- Strength
- 5 mg
- Imprint
- MP 578
- Color
- White
- Shape
- Capsule/Oblong
1 / 3
Loading
Logo Cephalon 15 mg
Cyclobenzaprine Hydrochloride Extended Release
- Strength
- 15 mg
- Imprint
- Logo Cephalon 15 mg
- Color
- Orange
- Shape
- Capsule/Oblong
Featured

Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Reviews & ratings

1 / 2
Loading
B15
Cyclobenzaprine Hydrochloride Extended Release
- Strength
- 15 mg
- Imprint
- B15
- Color
- Orange
- Shape
- Capsule/Oblong

1 / 2
Loading
B30
Cyclobenzaprine Hydrochloride Extended Release
- Strength
- 30 mg
- Imprint
- B30
- Color
- Red / Blue
- Shape
- Capsule/Oblong

T035 T035
Cyclobenzaprine Hydrochloride Extended-Release
- Strength
- 15 mg
- Imprint
- T035 T035
- Color
- Orange / Red
- Shape
- Capsule/Oblong

1 / 3
Loading
M 761

1 / 2
Loading
Logo Cephalon 30 mg
Cyclobenzaprine Hydrochloride Extended Release
- Strength
- 30 mg
- Imprint
- Logo Cephalon 30 mg
- Color
- Blue & Orange
- Shape
- Capsule/Oblong

Gr C10

T40 30 mg
Cyclobenzaprine Hydrochloride Extended-Release
- Strength
- 30 mg
- Imprint
- T40 30 mg
- Color
- Blue & Orange
- Shape
- Capsule/Oblong

A177 15
Cyclobenzaprine Hydrochloride Extended-Release
- Strength
- 15 mg
- Imprint
- A177 15
- Color
- Orange / Red
- Shape
- Capsule/Oblong

MYLAN CE 30 MYLAN CE 30
Cyclobenzaprine Hydrochloride Extended Release
- Strength
- 30 mg
- Imprint
- MYLAN CE 30 MYLAN CE 30
- Color
- Red / Green
- Shape
- Capsule/Oblong

MYLAN CE 15 MYLAN CE 15
Cyclobenzaprine Hydrochloride Extended Release
- Strength
- 15 mg
- Imprint
- MYLAN CE 15 MYLAN CE 15
- Color
- Red / Purple
- Shape
- Capsule/Oblong

APO C30
Cyclobenzaprine Hydrochloride Extended-Release
- Strength
- 30 mg
- Imprint
- APO C30
- Color
- Blue / Red
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.